27 results
To help immunization stakeholders make effective DPC decisions for their country context, the Dose Per Container Partnership (DPCP) has developed generalized information based on the partnership’s...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
This resource is a culmination of DPCP research results to provide decision makers with evidence that can be generalized to other countries when considering vaccine presentation.
Country- and...
Vietnam: Effects of Changing Dose per Container on the Immunization System
Vaccination in Zambia - Healthworker Experiences Using 5-dose MR Vaccine
Senegal: Weighing the Costs and Benefits of Changing DPC
Modeling to Support Decision-Making for 5-dose Measles-Rubella Routine Vaccination in Zambia
Measles Vaccination in Zambia: Balancing Coverage & Wastage
Information Gaps in Decision-Making on Vaccine Presentation in 3 Francophone Countries
Immunization Tools to Help the Dose Per Container Decision
Ghana: Understanding Changes in Vaccine Presentation
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Each year, IVAC prepares the Pneumonia and Diarrhea Progress Report and publishes it for World Pneumonia Day on November 12. The report evaluates the annual progress made in prevention and control of...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
IVAC is releasing a set of tools capturing and synthesizing the latest and best available data around rotavirus diseases and vaccines with technical decision-makers in mind. We have developed a...
To address the epidemiologic and diagnostic complexity of pneumococcal disease in particular, and to support our partners in their technical evaluations of pneumococcal disease and vaccines, we are...
IVAC is releasing a set of tools capturing and synthesizing the latest and best available data around pneumococcal diseases and vaccines with technical decision-makers in mind. We have developed a...
The global analysis, entitled Gap Analysis of Rotavirus Vaccine Impact Evaluations in Settings of Routine Use, is the output of an IVAC-maintained database of completed and ongoing vaccine impact...
The global analysis, entitled Gap Analyses of PCV Impact Evaluations in Settings of Routine Use, is the output of an IVAC-maintained database of completed and ongoing vaccine impact studies for these...
The VIEW-hub report: Global Vaccine Introduction and Implementation, is also now available. A summary companion to IVAC’s interactive VIEW-hub platform, the VIEW-hub report displays data and...
The 2016 Pneumonia and Diarrhea Progress Report: Reaching Goals Through Action and Innovation is the seventh annual Progress Report, but the first in the era of the Sustainable Development Goals...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...